TUBA1C and hepatocellular carcinoma: TUBA1C was found to be upregulated in hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC), where it predicted poor prognosis and facilitated cell proliferation and migration [6, 7].